Bile Duct Cancer clinical trials

Explore recruiting bile duct cancer clinical trials.

Recruiting bile duct cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bile Duct Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter study

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

[68Ga]Ga-FAPI-46 positron emission tomography in pancreatobiliary cancers: a pharmacokinetics, repeatability and diagnostic accuracy study. (PANSCAN-1)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study and cost-effectivity analysis.

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR/Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors

Netherlands, France, Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Bile Duct Cancer trials by city

Bile Duct Cancer in Toronto Bile Duct Cancer in Vancouver Bile Duct Cancer in Montreal Bile Duct Cancer in Calgary Bile Duct Cancer in Edmonton Bile Duct Cancer in Ottawa Bile Duct Cancer in Winnipeg Bile Duct Cancer in Quebec City Bile Duct Cancer in Hamilton Bile Duct Cancer in Kitchener Bile Duct Cancer in London Bile Duct Cancer in Halifax Bile Duct Cancer in New York Bile Duct Cancer in Los Angeles Bile Duct Cancer in Chicago Bile Duct Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease